Purified Vero Rabies Vaccine Serum Free (VRVg) + Imovax® Rabies: Human Diploid Cell Vaccine (HDCV),
Phase 2Completed 0 watching 0 views this week⚡ Active
51
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedAbout Purified Vero Rabies Vaccine Serum Free (VRVg) + Imovax® Rabies: Human Diploid Cell Vaccine (HDCV),
Purified Vero Rabies Vaccine Serum Free (VRVg) + Imovax® Rabies: Human Diploid Cell Vaccine (HDCV), is a phase 2 stage product being developed by Sanofi for Rabies. The current trial status is completed. This product is registered under clinical trial identifier NCT01930357. Target conditions include Rabies.
Hype Score Breakdown
Clinical
17
Activity
12
Company
9
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01930357 | Phase 2 | Completed |
Competing Products
20 competing products in Rabies